Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Depreciation & Amortization (CF) (2024 - 2025)

Connect Biopharma Holdings' Depreciation & Amortization (CF) history spans 2 years, with the latest figure at $179000.0 for Q3 2025.

  • For Q3 2025, Depreciation & Amortization (CF) rose 1.7% year-over-year to $179000.0; the TTM value through Sep 2025 reached $681000.0, up 35.66%, while the annual FY2024 figure was $660000.0, 8.33% down from the prior year.
  • Depreciation & Amortization (CF) for Q3 2025 was $179000.0 at Connect Biopharma Holdings, up from $171000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $179000.0 in Q3 2025 and bottomed at $158000.0 in Q4 2024.